News
-
-
PRESS RELEASE
Worksport Subsidiary Terravis Energy Selects Major Asian Manufacturing Partner for Breakthrough Zerofrost(TM) Heat Pump; Announces Path to Commercialization Within 2026
Worksport Ltd. secures major Asian manufacturing partner to mass-produce Aetherlux Pro Zerofrost Heat Pump, meeting global demand for breakthrough technology in 2026 -
PRESS RELEASE
Terravis Energy Secures Mass Manufacturing for No-Defrost Heat Pump Amid North American Polar Vortex Crisis
Terravis Energy, a Worksport Ltd. subsidiary, introduces mass-produced Aetherlux Pro Zerofrost™ Integrated Heat Pump, tackling energy bill spikes during extreme cold by eliminating defrost cycles and backup heat -
PRESS RELEASE
Skyhawk Therapeutics Announces Nine Month Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington's Disease
Skyhawk Therapeutics reports positive interim results in Phase 1 Clinical Trial of SKY-0515 for Huntington's Disease, showing promising data on disease progression and safety -
-
REGULATED PRESS RELEASE
Exercice de l’option de remboursement de l'instrument subordonné FR0010167296
CNP Assurances exerce l'option de remboursement de l'instrument subordonné FR0010167296, optimisant sa structure de capital. Détails sur https://www.cnp.fr/le-groupe-cnp-assurances/investisseurs/dettes -
REGULATED PRESS RELEASE
Notice of exercise of early redemption option of the subordinated note ISIN : FR0010167247
CNP Assurances announces early redemption of €225,000,000 subordinated notes ISIN FR0010167247 to optimize capital structure. Details on website. CNP Assurances Group is a leading insurer & investor -
REGULATED PRESS RELEASE
Exercice de l’option de remboursement de l'instrument subordonné FR0010167247
CNP Assurances exerce l'option de remboursement de l'instrument subordonné FR0010167247 pour optimiser sa structure de capital. Détails sur https://www.cnp.fr/le-groupe-cnp-assurances/investisseurs/dettes -
-
PRESS RELEASE
RAPPEL : Fermentalg organise une visioconférence destinée aux investisseurs particuliers mercredi 28 janvier 2026 à 17h30
Fermentalg organisera une visioconférence pour les investisseurs particuliers le 28 janvier 2026. La société présentera son portefeuille de BioSolutions, son chiffre d'affaires 2025 et les perspectives commerciales 2026